Edition:
United States

Biostar Pharmaceuticals Inc (BSPM.OQ)

BSPM.OQ on NASDAQ Stock Exchange Capital Market

3.86USD
16 Feb 2018
Change (% chg)

$-0.21 (-5.16%)
Prev Close
$4.07
Open
$4.15
Day's High
$4.15
Day's Low
$3.76
Volume
53,190
Avg. Vol
144,289
52-wk High
$5.96
52-wk Low
$1.18

Latest Key Developments (Source: Significant Developments)

Biostar Pharma qtrly ‍loss per share $0.05
Monday, 20 Nov 2017 04:01pm EST 

Nov 20 (Reuters) - Biostar Pharmaceuticals Inc ::Biostar Pharmaceuticals Inc. announces its quarterly results for nine months ended September 30, 2017.Biostar Pharmaceuticals Inc - qtrly ‍loss per share $0.05.  Full Article

Biostar Pharmaceuticals qtrly loss per share $‍0.50​
Wednesday, 15 Nov 2017 04:30pm EST 

Nov 15 (Reuters) - Biostar Pharmaceuticals Inc :Biostar Pharmaceuticals, Inc. announces its quarterly results for three months ended June 30, 2017.Biostar Pharmaceuticals Inc - ‍during fiscal Q2 of 2017 company recognized no net sales​.Biostar Pharmaceuticals Inc qtrly loss per share $‍0.50​.  Full Article

Biostar Pharmaceuticals Q1 loss per share $0.38
Friday, 19 May 2017 04:30pm EDT 

May 19 (Reuters) - Biostar Pharmaceuticals Inc :Biostar Pharmaceuticals Inc announces its quarterly results for three months ended March 31, 2017.Qtrly loss per share $0.38.Biostar Pharmaceuticals Inc - no net sales in Q1, a decrease of approximately $0.8 million or 100% as compared to same period in 2016.Biostar Pharmaceuticals Inc - currently anticipates that production of Shaanxi Weinan products will resume in Q2 of 2017.  Full Article

Betta Pharmaceuticals to invest in Beijing Biostar Technologies
Monday, 1 May 2017 11:36pm EDT 

May 2 (Reuters) - Betta Pharmaceuticals Co Ltd <300558.SZ> ::* Says it plans to take part in a new round of financing to boost capital of 50 million yuan in Beijing Biostar Technologies Ltd.* Says co will transfer 15 percent of the capital subscription to a tech firm which owned by technology and management team members of Beijing Biostar Technologies as incentive equity, for free .* And co will hold 4.5 percent stake in Beijing Biostar Technologies Ltd after transaction.  Full Article

Biostar Pharmaceuticals Inc anticipates production of Shaanxi Weinan products will resume in first half of 2017
Thursday, 13 Apr 2017 04:00pm EDT 

Biostar Pharmaceuticals Inc : Biostar Pharmaceuticals Inc announces its annual results for the year ended December 31, 2016 . Biostar Pharmaceuticals Inc - currently anticipates that production of Shaanxi Weinan products will resume in first half of 2017 . Biostar Pharmaceuticals-as a result temporary suspension of production, there may be substantial doubt regarding ability to continue as going concern . Biostar Pharmaceuticals Inc - currently anticipates that production of shaanxi weinan products will resume in first half of 2017 .Biostar Pharmaceuticals Inc - temporary suspension of production has materially negatively affected company's operating results.  Full Article

Biostar Pharmaceuticals Inc files for non-timely 10-K
Monday, 3 Apr 2017 04:22pm EDT 

Biostar Pharmaceuticals Inc :Biostar Pharmaceuticals Inc- files for non-timely 10-K.  Full Article

Biostar Pharmaceuticals files for non-timely quarterly report
Tuesday, 15 Nov 2016 09:37am EST 

Biostar Pharmaceuticals Inc :Biostar Pharmaceuticals Inc - Files for non-timely 10-Q - SEC filing.  Full Article

Biostar Pharmaceuticals signs a letter of intent to acquire Xianyang Yongsheng Health Products Co Ltd
Thursday, 22 Sep 2016 08:00am EDT 

Biostar Pharmaceuticals Inc : Biostar Pharmaceuticals signs a letter of intent to acquire Xianyang Yongsheng Health Products Co Ltd . To buy 100% of equity interest in Xianyang Yongsheng in exchange for cash payment, issuance of shares of Biostar's restricted common stock .Companies seek to complete this transaction in second half of 2016.  Full Article

Biostar Pharmaceuticals reports qtrly loss per share $3.12
Monday, 22 Aug 2016 04:00pm EDT 

Biostar Pharmaceuticals Inc : Announces its quarterly results for three months ended June 30, 2016 . Fiscal Q2 net sales of $0.6 million, a decrease of approximately $13.6 million .Qtrly loss per share $3.12.  Full Article

Biostar Pharmaceuticals files for non-timely 10-Q with U.S. SEC
Tuesday, 16 Aug 2016 04:02pm EDT 

Biostar Pharmaceuticals Inc : Files for non-timely 10-Q with U.S. SEC - SEC filing .Says expects that quarterly report that is subject hereof will be filed within the time frame allowed by the extension.  Full Article

BRIEF-Biostar Says Shaanxi Aoxing Renewed GMP Certification

* SHAANXI AOXING PHARMACEUTICAL CO., LTD. RENEWED ITS GMP CERTIFICATION